Pfizer

A company logo is seen through branches at a Pfizer office in Dublin, Ireland November 24, 2015. Credit: Reuters/Cathal McNaughton

Pharma Company Pfizer to Partner With Government on Drug Resistance

Big Pharma Firms May Have ‘Underpaid’ Rs 530 Crore in Indian Taxes: New Report

US Students Urge UCLA to Drop Proxy Patent Battle for Cancer Drug in India

Delhi’s RCEP Talks on Intellectual Property Shouldn’t Forget India’s Role as ‘Pharmacy of the World’

A recent report published by Medicins sans Frontieres (MSF) suggests that new generation of vaccines are prone to high concentration of patent evergreening. Credit: Pan America Health Organisation/Flickr CC BY-ND 2.0

WIPO Report Downplays Patent Barriers to Vaccine Access

How the University of California Is Fighting Proxy Patent Battle for Expensive Cancer Drug in India

A company logo is seen through branches at a Pfizer office in Dublin, Ireland November 24, 2015. Credit: Reuters/Cathal McNaughton

With Pneumococcal Vaccine Patent, Pfizer Wins on Many Counts